Applying Real-World Evidence to Improve Clinical Decision-Making for Patients with HR-positive/HER2-negative Metastatic Breast Cancer - a podcast by ReachMD

CME credits: 0.25

Valid until: 19-05-2021

Claim your CME credit at https://reachmd.com/programs/cme/applying-real-world-evidence-improve-clinical-decision-making-patients-hr-positiveher2-negative-meta/11530/

Skepticism regarding the use of real-world evidence continues to exist among oncologists, but in actuality, real-world studies can provide information that may aid clinicians in Europe who are treating patients with HR-positive/HER2-negative metastatic breast cancer, especially regarding the use of CDK 4/6 inhibitors.

This discussion focuses on the fundamental value that real-world evidence can provide in support of randomized clinical trials and how oncologists can best incorporate these data into current clinical practice.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD